Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy.
Saved in:
| Title: | Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy. |
|---|---|
| Authors: | Krebs, Simone1 (AUTHOR) krebss@mskcc.org, O'Donoghue, Joseph A.2 (AUTHOR), Biegel, Evan2 (AUTHOR), Beattie, Bradley J.2 (AUTHOR), Reidy, Diane3 (AUTHOR), Lyashchenko, Serge K.1,4,5 (AUTHOR), Lewis, Jason S.1,4,5 (AUTHOR), Bodei, Lisa1,5 (AUTHOR), Weber, Wolfgang A.1,5,6 (AUTHOR), Pandit-Taskar, Neeta1,5 (AUTHOR) |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. 2020, Vol. 47 Issue 13, p3047-3057. 11p. 3 Color Photographs, 2 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16197070 |
|---|---|
| DOI: | 10.1007/s00259-020-04832-9 |
